Local Institution - 1252 — Shelby, North Carolina

Local Institution - 1252 is a clinical research site located in Shelby, North Carolina, United States 28150-3803.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Local Institution - 1252 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Psychosis Associated With Alzheimer's Disease, Alzheimer Disease.

Sponsors: Karuna Therapeutics, Inc., a Bristol Myers Squibb company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Shelby

Browse all research sites in North Carolina · View every site in Shelby

• Atrium Health Cleveland/LCI-Cleveland
• Carolina Research Center
• GSK Investigational Site
• Novartis Investigative Site
• CORE
• Cleveland Hematology and Oncology Associates PC
• Research Site
• Vita Eye Clinic
• Shelby Clinical Research
• Novo Nordisk Investigational Site
• Carolinas HealthCare System Cleveland
• CYS-005 Investigational Site

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 1252?

Local Institution - 1252 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 1252 conducted?

Local Institution - 1252 has 2 clinical trials on record, with 2 currently active. Their work covers Psychosis Associated With Alzheimer's Disease, Alzheimer Disease.

Is Local Institution - 1252 accredited by Crixeo Clinical Trials?

Local Institution - 1252 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 1252?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.